Skip to content
★ Sign in to follow
Medinice S.A. logo

Medinice S.A. Stock: price and insider trades · Poland

PL·Mcap PLN 560.2MHealth Care

No insider purchase over the last 90 days. The latest, by ParmaNand Fundacja Rodzinna, was filed 17 Jul 2026.

Medinice S.A.: what insiders have been doing

Medinice S.A. belongs to the Health Care sector. Filings by its managers are published through KNF. 2 insiders have disclosed 6 filings since 22 October 2025.

Open-market activity splits into 3 purchases totalling €16.2M and 2 sales totalling €3.2M; 2 insiders sit on the buying side and 1 insider on the selling side. Netting one side against the other leaves €13.1M of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €13.4M, the purchase published on 17 July 2026 by ParmaNand Fundacja Rodzinna is the largest of the period (9.9% of market cap).

The data flag 1 purchase as part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (17 July 2026) now reads 115 days. Filings reach the KNF feed a median of 3 days after the trade. The regulation allows three business days to notify a trade (MAR article 19).

For context, the typical company on the same exchange (median of 553 companies) published 3 filings over the same period, against 6 filings here. Looking back to 2025, when coverage begins, insiders filed 3 purchases and 2 sales.

Every figure here comes from the filings published by KNF and describes the past, not future prices; it is not investment advice.

Insider Decl.
6
Thresholds
n/a
Buy Volume
€16M
3 ops. · all time
Sell Volume
€3M
2 ops. · all time

Who traded when

BuySale
ParmaNand Fundacja Rodzinna2 buys2 sales
Sanjeev Choudhary1 buy

Since the insiders bought

  • Filed 17 Jul 2026 · 115 days ago · €13.4M
    -30.8%
    Entry PLN 77.50 · Close 20 Oct 2026 PLN 53.60
  • Filed 11 Dec 2025 · 333 days ago · €2,600
    +151.9%
    Entry PLN 16.08 · Close at T+90 PLN 40.50

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

PLN 53.60
Analyst consensus
·
Income statement
Gross profit-PLN 166k
EBITDA-PLN 6.5M
Net income-PLN 6.7M0.0% margin
Valuation
P/Book5.9x
Beta1.05
Balance sheet & cash
Market capPLN 560.2M
Total debtPLN 365k
Free Cash Flow-PLN 11.7M
Debt / Equity1%
Profitability & ownership
ROE-9.7%
ROA-5.6%
% insiders23.5%
% institutions27.1%
Last declaration on 17 July 2026
Declarations6 total
  • ▲
    Osoba blisko związana z osobami pełniącymi obowiązki zarządcze: Sanjeev Choudhary - PrezesExecutives
    58M PLN25KNF
    1,165,000 shares@ PLN 50.009.88% mcap100.0% of flowShareWSEKNF:node/732591
    Canonical exit: 12 Oct 2026 (T+90)
  • ●
    Executives
    Executives
    0KNF
  • ▼
    Osoba blisko związana z osobami pełniącymi obowiązki zarządcze: Sanjeev Choudhary - PrezesExecutives
    1M PLN2KNF
    33,953 shares@ PLN 41.662.0% of flowShareWSEKNF:node/715454
  • ▲
    Osoba blisko związana z osobami pełniącymi obowiązki zarządcze: Sanjeev Choudhary - Prezes ZarząduExecutives
    12M PLN22KNF
    1,304,348 shares@ PLN 9.20100.0% of flowShareWSEKNF:node/712297
    Canonical exit: 8 Mar 2026 (T+90)
  • ▲
    Prezes ZarząduExecutives
    11,000 PLN10KNF
    110,000 shares@ PLN 0.10100.0% of flowShareWSEKNF:node/712293
    Canonical exit: 8 Mar 2026 (T+90)
  • ▼
    Osoba blisko związana z osobami pełniącymi obowiązki zarządcze: Sanjeev Choudhary - Prezes ZarząduExecutives
    12M PLN4KNF
    1,304,348 shares@ PLN 9.2017.1% of flowShareWSEKNF:node/711970

6 of 6 declarations

About Medinice S.A.

Medinice S.A. is a company listed on the XWAR market, specializing in the healthcare sector. It focuses on developing innovative solutions to enhance medical care.